$2.39T
Total marketcap
$71.48B
Total volume
BTC 50.50%     ETH 14.99%
Dominance

Kadimastem KMSTF Stock

6.4 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
5.49M USD
LOW - HIGH [24H]
6.4 - 6.4 USD
VOLUME [24H]
1K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.75 USD

Kadimastem Price Chart

Kadimastem KMSTF Financial and Trading Overview

Kadimastem stock price 6.4 USD
Previous Close 0.65 USD
Open 0.65 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.65 - 0.65 USD
52 Week Range 0.65 - 0.65 USD
Volume 400 USD
Avg. Volume 0 USD
Market Cap 23.66M USD
Beta (5Y Monthly) 0.69863
PE Ratio (TTM) N/A
EPS (TTM) -0.75 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

KMSTF Valuation Measures

Enterprise Value 27.26M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Kadimastem Stock Price History

Beta (5Y Monthly) 0.69863
52-Week Change 0%
S&P500 52-Week Change 20.43%
52 Week High 0.65 USD
52 Week Low 0.65 USD
50-Day Moving Average 0.65 USD
200-Day Moving Average 0.65 USD

KMSTF Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 36.41M
Float 12M
Short Ratio N/A
% Held by Insiders 64.23%
% Held by Institutions 10.95%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -69.072%
Return on Equity (ttm) -289.25%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -0.23
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) 2187.42 USD
Current Ratio (mrq) 0.704
Book Value Per Share (mrq) N/A

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Kadimastem

Country United States
State N/A
City Ness Ziona
Address Pinchas Sapir 7
ZIP 74140
Phone 972 73 797 1600
Website https://www.kadimastem.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 31

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel.

Q&A For Kadimastem Stock

What is a current KMSTF stock price?

Kadimastem KMSTF stock price today per share is 6.4 USD.

How to purchase Kadimastem stock?

You can buy KMSTF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Kadimastem?

The stock symbol or ticker of Kadimastem is KMSTF.

Which industry does the Kadimastem company belong to?

The Kadimastem industry is Biotechnology.

How many shares does Kadimastem have in circulation?

The max supply of Kadimastem shares is 857.57K.

What is Kadimastem Price to Earnings Ratio (PE Ratio)?

Kadimastem PE Ratio is now.

What was Kadimastem earnings per share over the trailing 12 months (TTM)?

Kadimastem EPS is -0.75 USD over the trailing 12 months.

Which sector does the Kadimastem company belong to?

The Kadimastem sector is Healthcare.